MedTrace Logo

Effect of the Administration of L-Carnitine on Body Weight in Women in Crossfit Training

NCT03436277 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2018-02-20

No results posted yet for this study

Summary

The L-carnitine has demonstrated effects in the treatment of obesity mainly promoting the fat degradation during exercise.

Conditions

  • Body Weight Changes

Interventions

DRUG

L-Carnitine

L-Carnitine oral solution 1.5 g diluted in 250 ml of water, before crossfit training, 5 times a week for 8 weeks

DIETARY_SUPPLEMENT

Sucralose

Sucralose 1.5 g diluted in 250 ml of water, before crossfit training, 5 times a week for 8 weeks

Sponsors & Collaborators

  • University of Guadalajara

    lead OTHER

Principal Investigators

  • Diana M Hernández · University of Guadalajara

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-17
Primary Completion
2019-02-28
Completion
2019-05-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03436277 on ClinicalTrials.gov